Cito Capital Group, LLC Charles River Laboratories International, Inc. Transaction History
Cito Capital Group, LLC
- $268 Million
- Q3 2024
A detailed history of Cito Capital Group, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cito Capital Group, LLC holds 1,150 shares of CRL stock, worth $188,025. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,150
Previous 1,150
-0.0%
Holding current value
$188,025
Previous $238,000
4.62%
% of portfolio
0.08%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
692Shares Held
52MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$997 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$832 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$612 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$348 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$317 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.32B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...